gracillin has been researched along with Colorectal Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Chen, X; Hu, W; Li, J; Li, Z; Shen, Y; Wang, C; Xiang, Y; Xiao, Z; Yang, L; Ye, H; Zhao, C; Zhao, H; Zhu, T | 1 |
1 other study(ies) available for gracillin and Colorectal Cancer
Article | Year |
---|---|
Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Spirostans; STAT3 Transcription Factor; Wound Healing; Xenograft Model Antitumor Assays | 2021 |